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Summary. To assess the role of non-compliance äs a cause of
instability in patients on oral anticoagulant therapy, a
follow-up study of stably and instably anticoagulated
patients and of patients beginning oral anticoagulant
therapy was performed. Compliance was assessed by pill
counting and with the use of pill bottles in the cap of
which a microprocessor registered the exact date and
time of opening of the bottle. (In)stability of oral anti-
coagulant therapy was expressed äs the number of INRs
and äs the time spent within the target ränge and by
squared sigma. Subsequently, äs a pilot study, a
randomized Intervention study in instable, non-compliant
patients was performed in which these patients were or were
not informed about the real nature of the cap of the pill
bottle.
Nineteen stable and 19 unstable patients and 30 patients
beginning therapy were followed for 3 months or less until
therapy stopped. Compliance was better in the previously
stably anticoagulated patients, although differences were
small. Poor compliance was not a major cause of instability
in patients starting therapy. Although the pilot Intervention
study was too small to assess the role of the special pill bottle,
it was shown that compliance can be positively affected.
Keywords: compliance, oral anticoagulant
instability, phenprocoumon, thrombosis Service.
therapy,
A number of clinical trials and other investigations have
shown the efficacy and relative safety of oral anticoagulant
therapy in atrial flbrillation, after myocardial infarction and
in patients with a mechanical heart valve prosthesis (Smith
et al, 1990; EAFT, 1993; ASPECT Research Group, 1994;
Atrial Fibrillation Investigators, 1994; Cannegieter et al,
1995; Hylek et al, 1996), and more Information has been
gathered about the optimal target ranges, expressed in
International Normalized Ratio (INR) (EAFT, 1993; Canne-
gieter et al, 1995; Hylek et al, 1996; Rosendaal, 1996).
Depending on the indication for therapy a minimal INR of
2-0 or 2-5 is essential for efficacy (Hüll et al, 1982; Schulman
& Lockner, 1985; Cannegieter et cd, 1995; The European
Atrial Fibrillation Trial Study Group, 1995; Rosendaal,
1996). The frequency of bleeding complications, however,
rises with INR (Fihn et al, 1993, 1996; Van der Meer et al,
1993, 1996; Cannegieter et al, 1995; The European Atrial
Fibrillation Trial Study Group, 1995). Therefore, narrow
target zones have been deflned at which the anticoagulant
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effect is aimed. Ideally, to achieve maximum efficacy and
minimal bleeding complications all treated patients should
be within the target ranges 100% of the time. Reality,
however, is different, and generally about 65-75% of INRs
are within the target ränge (Van den Besselaar et al, 1988;
Cannegieter et al, 1995; The European Atrial Fibrillation
Trial Study Group, 1995). Various explanations can be
offered for this phenomenon: analytical and biological
variability of the prothrombin time (Lassen et al, 1995),
dosage prescription (Fitzmaurice et al, 1996), intercurrent
diseases, interfering medicaments (Harder & Thürmann,
1996), dietary changes (Paterson & Kwaan, 1986) and,
rarely, inherited warfarin resistance (O'Reilly et al, 1964).
Poor compliance may also be a cause of instability. In
recent years there has been increasing literature on the
subject of compliance in various diseases and treatments.
Several methods are available to estimate compliance
(Urquhart, 1994). The older melhods such äs interviewing
the patient, pill counts and measurements of the drug
concentration in plasma all have disadvantages. A recently
introduced method is lo add a low-dose chemical marker to
the tablet (Pullar et al, 1988; Kumar, 1989). Low-dose
phenobarbital is frequently used äs a chemical marker
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because of its long half-Iife. Recently, Kumar et al (1989) used
this method in patients on warfarin therapy, and concluded
that poor compliance is a major cause of instability. In our
Thrombosis Service the majority of patients use the long-
acting coumarin derivative phenprocoumon (Marcoumar®).
Theoretically the long half-life should result in a more stable
anticoagulant control than with warfarin, because the effect
of taking a tablet too many or too few is not so drastic.
Nevertheless, we find patients with profound instability.
Therefore, either our instable patients are very poor
Compilers or the idea that long-acting drugs 'smooth out'
poor compliance is wrong. Because of the long half-life of
phenprocoumon we thought it less informative to add a
chemical marker with a long half-life to assess compliance.
Another recently introduced method to assess compliance
is the use of electronic monitoring devices which register
the date and time the pill bottle is opened (Gramer et al,
1989). This method is considered to give an accurate
reflection of oral drug administration (Urquhart, 1994).
Therefore we used this method to study the role of non-
compliance äs a cause of instability in our patients. Because
one cannot be sure that the patient actually took the
tablet with the use of this method (only the opening of the
bottle is registered) we decided to use this method in
combmation with pill counts. Furthermore, we assessed
the frequency of non-compliance in patients starting oral
anticoagulant therapy and performed a small trial to
improve compliance.
PATIENTS AND METHODS
The study consisted of three parts. In the first part
compliance was assessed and compared in patients who
were stably or unstably anticoagulated. In the second part,
compliance was assessed in patients starting oral anti-
coagulant therapy. The purpose of the third part was to
assess whether feedback information about poor compliance
could be used to improve compliance.
The design of the study was äs follows: after informed
consent the patients were examined, a short questionnaire
was filled out, and a special pill bottle was provided
(Medication Event Monitor Systems, Aprex Corporation,
Fremont, Calif., U.S.A.). The cap of these bottles contained a
microprocessor that registered the exact date and time the
bottle was opened. Special equipment and Computer Software
were provided by Aprex to retrieve the data from the cap. The
bottle was supplied to the patient with a pre-counted number
of tablets amply sufficient for the number of tablets the
patient had to take. For this purpose bottles prefllled with 15,
25, 40 or 50 tablets of phenprocoumon were provided by the
pharmacy department of the Academic Hospital of Leiden
(H. C. R. Brandenburg). The patients were checked at 14 d
intervals or more frequently when necessary. During that
visit a short history was taken about intercurrent illnesses,
changes in co-medication, changes in diet, smoking and
alcohol intake, bleeding complications, compliance and
events that might have had a serious impact on their lives.
Subsequently, the remaining tablets were changed for a fill-
up and counted. A blood sample was taken for INR
assessment on an Electra 1000C coagulometer (MLA,
Pleasantville, New York, U.S.A.) using the Thromborel S
reagent (Behringwerke AG, Marburg, Germany). According
to the routine procedure in our Thrombosis Service the
patient received a dosing list by mail the next day. The
patients were not informed about the füll purpose of the
study. Specifically, they were not informed about pill
counting and registration of the time of opening the pill
bottle. However, they were told that they were taking part in
a study concerning stability of anticoagulant treatment and
emphasis was put on the importance of diet, smoking,
alcohol intake and stress.
Patient selection
Patients were selected from those treated by the Leiden
Thrombosis Service (aboul 6500 patients). Only patients
who were treated for at least 6 months prior to this study
with the long-acting coumarin derivative phenprocoumon
(Marcoumar®) were eligible. Selection was not based on sex,
age, target ränge or indication for anticoagulant treatment.
Stable patients were deflned äs those who during the
previous 6 months had all their INR values within the
target ränge. Unstable patients were defined äs those who
had at least 50% of their INR values outside the target ränge
during the previous 6 months. Furthermore, the INR values
not within the ränge had to have been both under and above
the target ränge, so äs not to include patients who were
stably under- or over-anticoagulated. In the first part of the
study the patients were followed for 3 months.
The patients for the second part of the study were selected
from patients who were newly referred to our Thrombosis
Service for anticoagulant therapy. The patients were asked to
participate in the study äs soon äs possible after their first
visit, after which the protocol was identical to the first part.
Patients were followed for 3 months or less until therapy was
stopped.
In the third part of the study, patients were selected from
the patients proven unstable in the first two parts. They were
followed for 3 months. These patients were randomized in
two groups (closed envclope randomization in blocks; block
size 2). In group A the patients were informed about the füll
purpose of the study, the real working mechanism of the cap
of the pill bottles, and the counting of tablets. During this
part of the study at every check at the Thrombosis Service
the result of the pill counting and of the registration of
opening the pill bottle was discussed in relation to the
patient's own perception and recall and the INR results.
In group B the patients were not informed about the real
working mechanism of the cap and the counting of tablets.
At every check at the Thrombosis Service they were asked
about their compliance, and the importance of good
compliance was stressed in relation to the results of INR
assessment and (in)stability of the anticoagulant therapy.
All parts of the study were approved by the local Medical
Ethics Committee.
Statistics
Calculation oflhe time within the target ränge. For the whole
observation period the time within the target ränge was
© 1997 Blackwell Science Ltd, British Journal oj Haematologij 98: 893-900
calculated assuming a change of the INR on the mid-interval
between two visits (Van der Meer et al, 1993).
Compliance. All data on the exact date and time a pill bottle
was opened were registered. For every day it was assessed
whether the bottle was opened appropriately or not. Both too
many and too few openings were counted äs inadequate.
Days that no tablets had to be taken were taken into account.
The result was expressed äs a percentage of the observed
openings relative to the required openings.
As a measure of (ir)regularity in opening of the pill-bottle
the Standard deviation of the time (in minutes) between two
openings was calculated. Two (or more) openings within half
an hour were counted äs one. Days no tablets had to be taken
were taken into account. When the bottle was opened on a
day that no tablets had to be taken an extra 24h were added
to the opening time. In this way an extra opening was treated
equally to a missed opening.
Number of tablets. For each control-interval the number of
tablets that had to be taken was assessed. The result of the
pill counting was expressed äs a percentage of the number of
actually taken tablets relative to the number of tablets that
had to be taken.
As a measure of (in)stability of the level of anticoagulation
the square sigma (σ2) was calculated (Film et al, 1993;
Cannegieter et al, 1996). Sigma was deflned äs the slope of
the change of INR between successive visits, averaged over
all visits (Cannegieter et al, 1996). The lower the value of σ2
the more stable was the anticoagulant control.
Statistical analysis of the data was performed with the i-
test for independent samples wilh SPSS Software.
RESULTS
Patients
As indicated above, the patienls were not informed about the
real purpose of the study. As a consequence, several
interesting observations could be made and some problems
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in the Interpretation of the results arose. Despite our
instructions to take the tablets early in the evening, we
observed patients who systematically took them in the
morning or even during the night (between l and 3 a.m.).
A patient from the stable group of patients needed to take
half a tablet of phenprocoumon per day. It could be deduced
that he took out a whole tablet and did not put back the half.
As a result, many days were counted äs too few openings,
even though he most probably took half a tablet a day.
Two patients from the unstable group of the flrst pari of the
study probably also used another pill delivery System in
which the pills were laid out for a whole week. As a result the
pill bottle of the study was opened only once a week. One
patient in the second part of the study obviously regularly
forgot to take a tablet in the evening and took it the next
morning. This was counted äs two deviations. In the third
part of the study one patient of group B (the partially
informed group) probably started to use a pill delivery System
without informing us.
Pari I of the study
Nineteen stable and 19 unstable patients participated in the
flrst part of the study. Patient characteristics are shown in
Table I.
The main results are indicated in Table II. During the
study period the previously stable patient group remained
more stably anticoagulated than the previously unstable
group. The mean percentage of INR within the target ränge
was 75 (ränge 43-100) in the previously stable group
in contrast to 51 (ränge 14-100) in the previously
unstable group. The same difference was found when the
mean percentage of time within the target ränge was
considered: 75 (ränge 39-100) for the previously stable
group and 52 (ränge 15-100) for the previously unstable
group.
Also, σ2 äs measure of stability showed the most
stable anticoagulation in the previously stable patient
Table I. Patient characleristics.
No. of patients
Men/women
Mean age (ränge)
Target ränge*
Indication for anticoagulant therapy
Arterial thromboüc disease
Atrial fibrillation
Heart valve proslhesis
Venous thromboembolismt
PartI
Stable
19
16/3
61 (46-72)
M: 18
H: 1
17
1
1
—
Unstable
19
16/3
57 (27-74)
M: 13
H: 6
10
2
6
1
Part II
30
17/13
47 (16-74)
L:13
M:17
9
7
1
13
Part III
A
3
3/0
46 (27-64)
M:2
H:l
2
-
l
—
B
4
3/1
61(42-71)
M:3
H:l
1
1
1
1
* L (low) = INR 2-5-3-0-3-5; M (median) = INR 3-0-3-5-4-5; H (high) = INR 3-5-4-0-4·!
t Prophylaxis and treatment.
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group: 0-402 (ränge 0-017-1-2) versus 1-248 (ränge
0-058-3-329) in the previously unstable patient group.
Considering the opening of the pill bottle, the mean
percentage of 'good' opening in the previously stable patient
group was 88-2 (ränge 56-99) in contrast to 81-4 (ränge
15-100) in the previously unstable group. Both in the
previously stable, äs in the previously unstable patient
group, the pill bottle was opened too few times (mean
percentage 8-1 (ränge 0-39) and 14-3 (ränge 0-84)),
rather than too many times (mean percentage 3-7 (ränge 0—
14) and 4-3 (ränge 0-32)).
The variability of the time that the pill bottle was opened
was expressed by the Standard deviation of the time between
openings. In the previously stable patienl group the mean
Standard deviation was 513 min (ränge 206-1590) in
comparison to 947 min (ränge 195-3807) in the previously
unstable group.
In the previously stable patient group the mean percen-
tage of the number of pills that had been taken in relaüon to
the number that had to be taken was 99 (ränge 76-109) in
comparison to 104 (ränge 92-136) in the previously
unstable group.
In Fig l the percentage of time within the target zone in
relation to the percentage of 'good' opening of the pill bottle
is shown, both for the stable and the unstable patient group.
In Table II it can be seen that the differences between the
previously stable and unstable group were statistically
signiflcant for the percentage INR and the percentage time
within the target ränge and for the σ2. For the other
Parameters the differences were not signiflcant.
Part II of the study
Thirty patients starting oral anticoagulant therapy partici-
pated in the second part of the study. Patient characteristics
are shown in Table I and the main results in Table II. The
mean percentage of INR was 50 (ränge 0-100) and of time
within the target ränge was 49 (ränge 0-100). In this group
the mean σ2 äs a measure of stability was 0-903 (ränge
0-031-4-576). The mean percentage of 'good' opening of
the pill bottle was 92-8 (ränge 57-100). In this group the
mean percentage of opening the pill bottle too many times
was 3-7 (ränge 0-19), the same äs the mean percentage of
opening too few times: 3-5 (ränge 0-29). The mean
Standard deviation of the time between openings of the
pill bottle was 380 min (ränge 174-952). The mean
percentage of the number of pills taken adequately was 98
(ränge 76-109).
As can be seen in Fig 2, 24/30 patients (80%) opened the
pill bottle on the right day >90% of the time. Even among
these 24 near-perfect Compilers, only eight (33%) had their
INR within the target ränge for >70% of the time. Only half
(13/24) of them had their INR within the targel ränge for
>50% of the time.
Part III of the study
Seven patients participated in the third part of the study.
These patients were randomized between group A 'fully
informed' (three patients) and B 'partially informed' (four
patients). The characteristics of the patients are shown in
1997 Blackwell Science Ltd, British Journal of Haematology 98: 893-900
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Fig 3. INRs (*) and Standard deviation of the opening of the pill bettle m minules (D) for the patient of the case history.
deviation of the time between bottle openings was lower in
group A (603, ränge 373-992) than in group B (1043,
ränge 173-2701). There was no difference in the mean
percentage of the number of puls taken: group A 99%, ränge
97-102%; group B 103%, ränge 81-132%. Mean σ2 was
lower in group B (0-8667, ränge 0-094-1-853) than in
group A (1-737, ränge ΟΊ89-4Ό4).
Illustrative case history of a remarkable patient
A 27-year-old man, well known to our Thrombosis Service
because of his supposed poor compliance, used oral anti-
coagulants because of prosthetic heart valve Implantation in
1992 (Carbomedics, in mitral and in aorüc Position). He was
known to abuse alcohol, and have psychological and social
Problems; he smoked but did not use drugs. His anti-
coagulant control was invariably bad, with INR values
varying from 2-1 to 9-1, and seldom within the target ränge,
but he did attend the clinic at regulär intervals. The
prescribed dose of phenprocoumon also varied largely
because of his instability and poor compliance: between a
mean daily dose of 0-85 and 1-40 tablets. During the flrst
pari of the study his control remained poor. There was a
large Variation of INR values (from 1-8 to 6-0; Fig 3).
Frequently, he forgot to take his tablets from the special study
pill bottle and he forgot to take the bottle back to the
Thrombosis Service. So in the first pari of the study it was
virtually impossible to evaluate the number of tablets he took
and the times he opened the bottle. Despite this he was
motivated to improve his behaviour and he agreed in
participation in the third part of the study. He was
randomized to group A, so he was fully informed about the
purpose of the study and the nature of the special pill bottle.
Discussing his compliance in relation to the achieved INRs
and informing him repeatedly about the need for good
anticoagulant control and the inefflcacy and dangers of
bad control improved his compliance considerably. In the
flrst 8 weeks of the third part of the study he did not take his
tablets from the study bottle in 16/59 days, whereas in the
last 47 days he only missed 2 days. The percentage of tablets
he took improved from 88% to 100%. The Standard
deviation of the time between openings of the pill bottle
shortened considerably (Fig 3). In contrast to the flrst 8
weeks, his INR was, in the last 47 days, always within the
target ränge (Fig 3). This case history shows that it is possible
to improve compliance by giving extra attention and
Information to the patient. However, the extra value of the
special pill bottle to help the feedback cannot be deduced
from a single case.
ÜISCUSSION
The results of part I of the study indicate that the method
we used is effective in assessing compliance in patients
on oral anticoagulant therapy. Patients who were stably
anticoagulated prior to our study remained more stably
anticoagulated during the study period in comparison to the
© 1997 Blackwell Science Ltd, Sntish Journal of Haeinalology 98: 893-900
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previously unslable group. The previously stable patients
opened the pill bottle more often on the prescribed day,
indicating a better compliance, allhough the difference was
not statistically significant. The variability of the opening
times of the pill bottle was also less in these patients. The
mean percentage of tablets taken in the two groups, however,
did not differ materially (94% and 104%), which indicates
that pill counts are an insensitive method to assess
compliance in this setting.
We started this study with the hypothesis that poor
compliance was an important cause of instability. Although
we found some differences in compliance between the
previously stable patient group and the previously unstable
group, this was much less than we had expected. Therefore
although poor compliance contributes to instability, it clearly
is not the only, and possibly a minor, factor.
Patients starting oral anticoagulant therapy were ana-
lysed in part II of the study. It can be deduced both from
Table II and Fig 2 that äs a group these patients took their
tablets regularly and äs prescribed. In fact their compliance
was better than the compliance of the stable patients of
part I. Despite their good compliance, many patients were
not adequately anticoagulated. Although inadäquate anti-
coagulation is frequent among Starters, poor compliance
clearly is not a major cause of the instability. Probably,
correct dose determination is a major contributor to
instabilily in these patients.
In part III of the study we evaluated whether it was
possible to improve compliance and we assessed the possible
role of the special pill bottle in this regard. The number of
patients in our study was small and the sludy should be
interpretated äs a pilot study. From Table II and the case
history it appears that compliance can be improved by
special attention and devices. The patients were checked
more frequently and were seen separately by one of the
investigators. The extra attention, together with the extra
Information on the value of stable anticoagulant therapy and
the risks of instability, played a major role in their
improvement. The additive value of the special pill bottle to
this improvement is difflcult to assess. Further studies are
necessary in this regard.
The purpose of our study was to assess the frequency of
poor compliance and the role of poor compliance äs a cause
of unstable anticoagulant control. Therefore we decided not
to teil the patients about the background of the study and the
real purpose of the special pill bottles. Informing the patients
would probably have resulted in a change of behaviour and
compliance; this study would then be seen äs a behavourial
scientiflc sociological rather than a medical experiment. In
behavourial sociological sciences it is accepted that, when
desirable, participants are not fully informed. Our local
Medical Ethics Committee agreed with the procedure äs
described after a small adjustment of the original protocol.
The original plan was to give the patients another
explanation for the special pill bottles; this was changed,
however, to giving no explanation at all and leaving the
matter of the pill bottle unmentioned. When a few patients
persistently asked about the bottles we admitted that the
bottles were designed to measure compliance. After the study
was completed and analysed all patients were informed
about the real nature of the study and the pill bottles. In the
same letter the patient's own results were given. Not one
patient reacted negatively about not being informed; we feel
this is a justification of our approach.
As a result of not giving füll Information a number of
Problems arose which made the Interpretation of the results
more difflcult. Nevertheless, the results of our study provide
valuable Information on the role of compliance in the
stability of patients on oral anticoagulanl therapy.
ACKNOWLEDGMENT
This study was supported by grant 93.001 of the Trombose
Stichting Nederland.
REFERENCES
Anticoagulants in the Secondary Prevention of Events in Coronary
Thrombosis (ASPECT) Research Group (1994) Effect of long-term
oral anticoagulant treatment on mortality and cardiovascular
morbidity after myocardial infarction. Lcmcei, 343, 499-503.
Atrial Fibrillation Investigators (1994) Risk factors for stroke and
efficacy of antithrombotic therapy in atrial fibrillaüon. Archives of
Intemal Mediane, 154, 1449-1457.
Cannegieter, S.C., Rosendaal, ER., Bollen, W.L.E.M. & Briet, E.
(1996) Risk factors for ischemic and hemorrhagic stroke in the
anticoagulant treatment of patients with mechanical heart valve
prostheses. In: Optimal oral anticoagulant therapy in patients
with mechanical heart valves (Thesis).
Cannegieter, S.C., Rosendaal, ER., Wintzen, A.R., Van der Meer,
F.J.M., Vandenbroucke, J.P. & Briet, E. (1995) Optimal oral
anticoagulant therapy in patients with mechanical heart valves.
New England Journal ofMedicine, 333, 11-17.
Gramer, J.A., Mattson, R.H., Prevey, M.L.. Scheyer, R.D. & Ouelette,
V.L. (1989) How often is medication taken äs prescribed? A novel
assessment technique. Journal of Ihe American Medical Association,
261, 3273-3277.
EAFT (European Atrial Fibrillation Trial) Study Group (1993)
Secondary prevention in non-rheumatic atrial fibrillation after
transient ischaemic attack or minor stroke. Lancet, 342, 1255-1262.
Fihn, S.D., Callahan, C.M., Martin, D.C., McDonell, M.B., Henikoff,
J.G. & White, R.H. (1996) The risk for and severity of bleeding
complications in elderly patients treated with warfarin. Armais of
Intemal Mediane, 124, 970-979.
Fihn, S.D., McDonell, M., Martin, D., Henikoff, ]., Vermes, D„ Kent, D.
& White, R.H. (1993) Risk factors for complications of chronic
anticoagulation. Annals oflnternal Medidnc, 118, 511-520.
Fitzmaurice, D.A., Hobbs, F.D.R. & Murray, J.A. (1996) Monitoring
oral anticoagulation in primary care: quality assurance and
computerised decision support will help to minimise incon-
sistensies. Briüsh Medical Journal, 312, 1431-1432.
Harder, S. & Thürmann, P. (1996) Clinically important drug
interacüons with anticoagulants: an Update. Clinical Phannaco-
kinetics, 30, 416-444.
Hüll, R., Hirsh, T., Jay, R., Carter, C., England, C., Gent, M., Turpie,
A.G.G., McLouglin, D., Dodd, P., Thomas, M., Raskob, G. &
Ockelford, P. (1982) Different intensities of oral anticoagulant
therapy in the treatment of proximal-vein thrombosis. New
England Journal of Mediane, 307, 1676-1681.
Hylek, E.M., Skates, S.J., Sheehan, M.A. & Singer, D.E. (1996)
An analysis of the lowest effective intensity of prophylactic
© 1997 Blackwell Science Ltd, Brilish Journal of Haemalology 98: 893-900
900 Felix J. M. van der Meer et al
anticoagulation for patients with nonrheumatic atnal fibnllation
New England Journal of Mediane, 335, 540-546
Kumar, S , Haigh, JRM. , Rhodes, L E , Peaker, S , Davies, J A ,
Roberts, B E & Feely, M P (1989) Poor compliance is a major
factor m unstable outpatient control of anticoagulant therapy
Thrombosis and Haemosiasis, 62, 729—732
Lassen, JE, Brandslund, I & Antonsen, S (1995) International
normalized ratio for prothrombm times m patients taking oral
anticoagulants cntical difference and probabihty of signiflcant
change m consecutive measurements Chmcal Chemistry, 41,
444-447
O'Reilly, R A , Aggeler, PM , Silvija Hoag, M , Leong L S &
Kropatkm, M L (1964) Hereditary transmission of exceptional
resistance to coumarm anticoagulant drugs New England Journal
of Mediane, 271, 809-815
Paterson, PE & Kwaan, H C (1986) Current concepts of warfarm
therapy Archives of Internal Mediane, 146, 581-584
Pullar, T, Birtwell, A J , Wiles, PG , Hay, A & Feely, M P (1988) Use
of a pharmacologic mdicator to compare compliance with tablets
prescnbed to be taken once, twice, or three times daily Chmcal and
Pharmacological Therapeutics, 44, 540-545
Rosendaal, ER (1996) The Scylla and Charybdis of oral anticoagulant
treatment New England Journal of Mediane, 335, 587-589
Schulman, S & Lockner, D. (1985) Relationship between thrombo-
embolic complications and mtensity of treatment durmg
long-term prophylaxis with oral anticoagulants followmg
DVT Thrombosis and Haemosiasis, 53, 137-140
Smith, P, Arnesen, H & Holme, I (1990) The effect of warfarm on
mortality and remfarction after myocardial infarction New
England Journal of Mediane, 323, 147-152
The European Atnal Fibnllation Tnal Study Group (1995) Optimal
oral anticoagulant therapy m patients with nonrheumatic atnal
fibnllation and recent cerebral ischemia New England Jout nal of
Mediane, 333, 5-10
Urquhart, J (1994) Role of patient compliance m clmical
pharmacokmetics a review of recent research Clmical Pharmaco-
kmetics, 27, 202-215
Van den Besselaar, A M H P, Van der Meer, FJ M & Gernts-Drabbe,
C W (1988) Therapeutic control of oral anticoagulant treatment
in the Netherlands American Journal of Clmical Pathology, 90,
685-690
Van der Meer, FJ M , Rosendaal, FR , Vandenbroucke, J P & Briet, E
(1993) Bleeding complications m oral anticoagulant therapy an
analysis of nsk factors Archives of Internal Mediane, 153, 1557—
1562
Van der Meer, FJ M , Rosendaal, ER , Vandenbroucke, J P & Briet, E
(1996) Assessment of a bleedmg nsk mdex in two cohorts of
patients treated with oral anticoagulants. Thrombosis and
Haemosiasis, 76, 12-16
1997 Blackwell Science Ltd, British Journal of Haematology 98 893-900
